{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:53:29Z","timestamp":1776329609577,"version":"3.50.1"},"reference-count":32,"publisher":"Baskent University","issue":"Suppl 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.6002\/ect.mesot2023.p98","type":"journal-issue","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T08:17:17Z","timestamp":1708071437000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"22","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Ronco C, Reis T, Husain-Syed F. Management of acute kidney injury in patients with COVID-19. Lancet Respir Med. 2020;8(7):738-742. doi:10.1016\/S2213-2600(20)30229-0","DOI":"10.1016\/S2213-2600(20)30229-0"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Fisher M, Prudhvi K, Brogan M, Golestaneh L. Providing care to patients with AKI and COVID-19 infection: experience of front line nephrologists in New York. Kidney360. 2020;1(6):544-548. doi:10.34067\/KID.0002002020","DOI":"10.34067\/KID.0002002020"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513. doi:10.1016\/S0140-6736(20)30211-7","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-838. doi:10.1016\/j.kint.2020.03.005","DOI":"10.1016\/j.kint.2020.03.005"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. doi:10.1016\/S0140-6736(20)30566-3","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Kissling S, Rotman S, Gerber C, et al. Collapsing glomerulopathy in a COVID-19 patient. Kidney Int. 2020;98(1):228-231. doi:10.1016\/j.kint.2020.04.006","DOI":"10.1016\/j.kint.2020.04.006"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-280 e278. doi:10.1016\/j.cell.2020.02.052","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Pan XW, Xu D, Zhang H, Zhou W, Wang LH, Cui XG. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med. 2020;46(6):1114-1116. doi:10.1007\/s00134-020-06026-1","DOI":"10.1007\/s00134-020-06026-1"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Perico L, Benigni A, Remuzzi G. Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade. Nephron. 2020;144(5):213-221. doi:10.1159\/000507305","DOI":"10.1159\/000507305"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Larsen CP, Bourne TD, Wilson JD, Saqqa O, Sharshir MA. Collapsing glomerulopathy in a patient with COVID-19. Kidney Int Rep. 2020;5(6):935-939. doi:10.1016\/j.ekir.2020.04.002","DOI":"10.1016\/j.ekir.2020.04.002"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Oxley TJ, Mocco J, Majidi S, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020;382(20):e60. doi:10.1056\/NEJMc2009787","DOI":"10.1056\/NEJMc2009787"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Coca SG. Outcomes and renal function trajectory after acute kidney injury: the narrow road to perdition. Kidney Int. 2017;92(2):288-291. doi:10.1016\/j.kint.2017.03.044","DOI":"10.1016\/j.kint.2017.03.044"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Wright JT, Jr, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2002;288(19):2421-2431. doi:10.1001\/jama.288.19.2421","DOI":"10.1001\/jama.288.19.2421"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet. 2019;394(10212):1949-1964. doi:10.1016\/S0140-6736(19)32563-2","DOI":"10.1016\/S0140-6736(19)32563-2"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Zamoner W, Santos C, Magalhaes LE, de Oliveira PGS, Balbi AL, Ponce D. Acute kidney injury in COVID-19: 90 days of the pandemic in a Brazilian public hospital. Front Med (Lausanne). 2021;8:622577. doi:10.3389\/fmed.2021.622577","DOI":"10.3389\/fmed.2021.622577"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Ghinai I, McPherson TD, Hunter JC, et al. First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA. Lancet. 2020;395(10230):1137-1144. doi:10.1016\/S0140-6736(20)30607-3","DOI":"10.1016\/S0140-6736(20)30607-3"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi:10.1016\/S0140-6736(20)30183-5","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Hirsch JS, Ng JH, Ross DW, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98(1):209-218. doi:10.1016\/j.kint.2020.05.006","DOI":"10.1016\/j.kint.2020.05.006"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Procaccini FL, Alcazar Arroyo R, Albalate Ramon M, et al. Acute kidney injury in 3182 patients admitted with COVID-19: a single-center, retrospective, case-control study. Clin Kidney J. 2021;14(6):1557-1569. doi:10.1093\/ckj\/sfab021","DOI":"10.1093\/ckj\/sfab021"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720. doi:10.1056\/NEJMoa2002032","DOI":"10.1056\/NEJMoa2002032"},{"key":"ref20","unstructured":"21. Intensive Care National Audit & Research Centre. ICNARC report on COVID-19 in critical care, 2020. Accessed April 21, 2020. https:\/\/www.icnarc.org\/DataServices\/Attachments\/Download\/c31dd38d-d77b-ea11-9124-00505601089b"},{"key":"ref21","unstructured":"22. Abelson R, Fink S, Kulish N, Thomas K. An overlooked, possibly fatal coronavirus crisis: a dire need for kidney dialysis. New York Times. 2020. Accessed April 24, 2020. https:\/\/www.nytimes.com\/2020\/04\/18\/health\/kidney-dialysis-coronavirus.html"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23 Sarangarajan R, Winn R, Kiebish MA, Bountra C, Granger E, Narain NR. Ethnic prevalence of angiotensin-converting enzyme deletion (D) Polymorphism and COVID-19 risk: rationale for use of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers. J Racial Ethn Health Disparities. 2021;8(4):973-980. doi:10.1007\/s40615-020-00853-0","DOI":"10.1007\/s40615-020-00853-0"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Sanchis-Gomar F, Lavie CJ, Mehra MR, Henry BM, Lippi G. Obesity and outcomes in COVID-19: when an epidemic and pandemic collide. Mayo Clin Proc. 2020;95(7):1445-1453. doi:10.1016\/j.mayocp.2020.05.006","DOI":"10.1016\/j.mayocp.2020.05.006"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Bucuvic EM, Ponce D, Balbi AL. Risk factors for mortality in acute kidney injury. Rev Assoc Med Bras (1992). 2011;57(2):158-163. doi:10.1590\/s0104-42302011000200012","DOI":"10.1590\/S0104-42302011000200012"},{"key":"ref25","unstructured":"26. Garcia TP, Romero MP, Poletti NA, Cesarino CB, Ribeiro RC. Principais motivos de interna\u00e7\u00e3o do paciente com insufici\u00eancia renal aguda na unidade de terapia intensiva. Arq Ci\u00eanc Sa\u00fade. 2005:138-142."},{"key":"ref26","unstructured":"27. Dos Santos ER, de Matos JD. Perfil epidemiologico dos pacientes com inj\u00faria renal aguda em uma unidade de terapia intensiva. Arq Catarinenses Med. 2008;37(4):1806."},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411-1423. doi:10.1007\/s00134-015-3934-7","DOI":"10.1007\/s00134-015-3934-7"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Kellum JA, Murugan R. Effects of non-severe acute kidney injury on clinical outcomes in critically ill patients. Crit Care. 2016;20(1):159. doi:10.1186\/s13054-016-1295-4","DOI":"10.1186\/s13054-016-1295-4"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. Annigeri RA, Ostermann M, Tolwani A, et al. Renal support for acute kidney injury in the developing world. Kidney Int Rep. 2017;2(4):559-578. doi:10.1016\/j.ekir.2017.04.006","DOI":"10.1016\/j.ekir.2017.04.006"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Pannu N, Klarenbach S, Wiebe N, Manns B, Tonelli M; Alberta Kidney Disease Network. Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA. 2008;299(7):793-805. doi:10.1001\/jama.299.7.793","DOI":"10.1001\/jama.299.7.793"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol. 2020;16(6):308-310. doi:10.1038\/s41581-020-0284-7","DOI":"10.1038\/s41581-020-0284-7"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T03:25:47Z","timestamp":1708313147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/supplement\/2024\/22\/1\/1\/290\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":32,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2024,1]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.mesot2023.p98","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}